Title Created Date
A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia 19 January 2017
The antiproliferative effects of melatonin on experimental pituitary and colonic tumors. Possible involvement of the putative nuclear binding site? 23 December 2016
Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway 23 December 2016
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238 08 December 2016
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system 02 December 2016
Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status 30 November 2016
Melatonin and human cancer 04 November 2016
Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro 03 November 2016
Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation 01 November 2016
Use of the somatostatin analogue octreotide to localise and manage somatostatin-producing tumours 19 October 2016
Display #